Vela Diagnostics

Vela Diagnostics, National Cancer Center of Singapore to Develop CDx for EGFR-TKI Therapies

Vela Diagnostics and NCCS will evaluate the efficacy of the assay in a clinical trial to test the response of patients to EGFR-TKI therapies.